Christopher Sarchi - 01 Jun 2026 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Reporting relationship: Chief Commercial Officer
Issuer ticker: REPL
Reported as of: 01 Jun 2026
Net transaction value: -$110,880
SEC form: 4
Accepted by SEC: 03 Jun 2026, 20:30:04 UTC
Prior SEC filing: 20 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Shawn Glidden, attorney-in-fact

Key filing fact

Christopher Sarchi filed Form 4 for Replimune Group, Inc. (REPL) on 03 Jun 2026.

Key facts

This page summarizes Christopher Sarchi's Form 4 filing for Replimune Group, Inc. (REPL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2026, 20:30.

Change

Previous filing in this sequence was filed on 20 May 2026.
Current net transaction value: -$110,880.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001986597 Primary reporting owner

Sarchi Christopher

Relationship: Chief Commercial Officer
Address: C/O REPLIMUNE GROUP, INC., 500 UNICORN PARK DRIVE, SUITE 303, WOBURN
Signature: /s/ Shawn Glidden, attorney-in-fact
Signature date: 03 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REPL transaction

Common Stock

Sale

Transaction value: $110,880
Shares: -12,000
Change %: -6.2%
Price: $9.24
Shares after: 180,962
Date: 01 Jun 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Christopher Sarchi is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sales reported on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on December 15, 2025, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

Footnote F2

The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $9.15 to $9.62 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range.